Evidence map›Paper›PMID 40483308›Full record

ArticleNPJ systems biology and applications2025

Assessment of plasma derived microbiome profiles in lung cancer using targeted and whole exome sequencing.

Vichitra Behel, Supriya Hait, Vanita Noronha, Aniket Chowdhury, Pratik Chandrani, Vijay Patil, Nandini Menon, Rohit Mishra, Bhargavi Bawaskar, Ganesh Dahimbekar and 12 more

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Vichitra Behel *Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Supriya Hait *Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, Maharashtra, India.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Aniket ChowdhuryHomi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, Maharashtra, India.
Pratik ChandraniDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Vijay PatilDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Nandini MenonDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Rohit MishraIntegrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India.
Bhargavi BawaskarIntegrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India.
Ganesh DahimbekarIntegrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India.
Minit ShahDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Rajiv KaushalHomi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, Maharashtra, India.
Vidya Veldore4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotech, Bengaluru, Karnataka, India.
Hitesh Goswami4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotech, Bengaluru, Karnataka, India.
Atul BhardeOneCell Diagnostics, Pune, Maharashtra, India.
Jayant KhandareOneCell Diagnostics, Pune, Maharashtra, India.
Gowhar ShafiOneCell Diagnostics, Pune, Maharashtra, India.
Anuradha ChoughuleDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Neetu TyagiIntegrated Cancer Genomics Laboratory, Department of Genetics, University of Delhi South Campus, New Delhi, India.
Sanket DesaiHomi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, Maharashtra, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India. kumarprabhashtmh@gmail.com.
Amit DuttIntegrated Cancer Genomics Laboratory, Department of Genetics, University of Delhi South Campus, New Delhi, India. amitdutt@south.du.ac.in.

Funding

Indian Council of Medical Research 01/ICMRCAREP-2023-0000278/AD/DevDiv
6 · The paper itself

Abstract

Microbial infections contribute to ~20% of malignancy. Plasma-derived cell-free DNA presents a promising avenue for non-invasive cancer diagnostics, capturing microbial signatures. We analyzed 261 plasma from 50 patients with lung adenocarcinoma by targeted and whole exome sequencing at 10,000 × and 340 × depth, respectively. Comparative analyses of Kraken 2 and IPD2 reveal substantial discrepancies, highlighting challenges in microbial DNA quantification and the need for stringent bioinformatics approaches to ensure accurate cancer microbiome profiling.

Indexed as

Exome SequencingLung NeoplasmsMicrobiotaAdenocarcinoma of LungAgedComputational BiologyFemaleHumansMaleMiddle Aged

Identifiers

PMID40483308
PMCPMC12145415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.